12 March 2002
Distinct regions of loss of heterozygosity on 22q in different sites of head and neck squamous cell carcinomas.
Patricia Pintor dos Reis, Regina Célia Poli-Frederico, Rodrigo Mattos dos Santos, Ines Nobuko Nishimoto, Luiz Paulo Kowalski, Silvia Regina RogattoMed Sci Monit 2002; 8(3): BR89-94 :: ID: 420893
Abstract
BACKGROUND: Frequent loss of heterozygosity (LOH) has been reported inmany types of cancer, including head and neck carcinomas. Somatic deletions involving specific chromosomalregions are strongly associated with inactivation of the allele of a tumor suppressor gene located withinthe deleted region. In most studies concerning LOH in head and neck squamous cell carcinomas (HNSCC)the different anatomical sites are not distinguished. The behavior of tumors arising at various sitesdiffers significantly, however, suggesting different intrinsic tumor properties. In this study we comparedthe LOH on 22q and its relationship to clinicopathological parameters at the three major sites of HNSCC:oral cavity, larynx and pharynx. MATERIAL/METHODS: LOH and microsatellite instability (MSI) were studiedusing seven polymorphic microsatellite markers mapped to the 22q11-q13.3 region in 37 oral, 32 laryngeal,and 31 pharyngeal carcinomas. RESULTS: Two separate regions of LOH were identified in the laryngeal (22q11.2-12.1)and oral cavity (22q13.1-13.31) tumors. When the different anatomical sites were compared, a statisticallysignificant difference was found between the presence of LOH at D22S421 (p<0.001), D22S315 (p=0.014) and D22S929 (p=0.026) in the laryngeal tumors.
Conclusions: These data suggest that distinct regions on 22q are involved in LOH in oral cavity and laryngeal tumorigenesis, but do not support a similar association between the development of pharyngeal tumors and genes located on 22q. These findings implicate the presence of different tumor suppressor genes mapping to distinct regions on chromosome 22q in oral and laryngeal carcinomas.
Keywords: Alleles, Carcinoma, Chromosomes, Human, Pair 22, Gene Deletion, Head and Neck Neoplasms, Laryngeal Neoplasms, Loss of Heterozygosity, Microsatellite Repeats, Models, Genetic, Pharyngeal Neoplasms, Research Support, Non-U.S. Gov
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952